2D and 3D Deep Learning Models for MRI-based Parkinson's Disease Classification: A Comparative Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks

Abstract

Parkinson's Disease (PD) diagnosis remains challenging. This study applies Convolutional Kolmogorov-Arnold Networks (ConvKANs), integrating learnable spline-based activation functions into convolutional layers, for PD classification using structural MRI. The first 3D implementation of ConvKANs for medical imaging is presented, comparing their performance to Convolutional Neural Networks (CNNs) and Graph Convolutional Networks (GCNs) across three open-source datasets. Isolated analyses assessed performance within individual datasets, using cross-validation techniques. Holdout analyses evaluated cross-dataset generalizability by training models on two datasets and testing on the third, mirroring real-world clinical scenarios. In isolated analyses, 2D ConvKANs achieved the highest AUC of 0.99 (95% CI: 0.98-0.99) on the PPMI dataset, outperforming 2D CNNs (AUC: 0.97, p = 0.0092). 3D models showed promise, with 3D CNN and 3D ConvKAN reaching an AUC of 0.85 on PPMI. In holdout analyses, 3D ConvKAN demonstrated superior generalization, achieving an AUC of 0.85 on early-stage PD data. GCNs underperformed in 2D but improved in 3D implementations. These findings highlight ConvKANs' potential for PD detection, emphasize the importance of 3D analysis in capturing subtle brain changes, and underscore cross-dataset generalization challenges. This study advances AI-assisted PD diagnosis using structural MRI and emphasizes the need for larger-scale validation.